Why the study?
Does temocapril effectively block angiotensin II generation and reduce pressor responses to angiotensin I in normal volunteers?
Does temocapril effectively block angiotensin II generation and reduce pressor responses to angiotensin I in normal volunteers?
Answers are grounded in this paper and cite their sources.
In vivo ACE activity, estimated by the plasma Ang II/Ang I ratio, reliably predicts the decrease in angiotensin-dependent blood pressure achieved by ACE inhibitors.
In a double-blind study, we compared the value of different approaches to assess blockade of angiotensin (Ang) II generation in 10 normal volunteers treated with the new Ang-converting enzyme (ACE) inhibitor temocapril. Plasma concentration of the diacid active metabolite of temocapril, plasma Ang I and II levels, plasma ACE activity, and inhibition of the pressor response to repeated intravenous (i.v.) doses of Ang I were measured before and repeatedly after different doses of tempocapril or placebo. In vivo ACE activity, estimated by the plasma Ang II/Ang I ratio, correlated well with temocapril diacid concentration (r = 0.85, n = 148) and with systolic and diastolic blood pressure (SBP, DBP) responses to Ang I (r = 0.76 and r = 0.79, n = 148). SBP and DBP responses to Ang I were also strongly related to temocapril diacid concentration (r = -0.81 and r = -0.88, n = 148). ACE activity measured in vivo reliably predicts the decrease in Ang-dependent BP to be achieved by ACE inhibitors.
No takes yet. Share an insight, caveat, or question.
Delacrétaz et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: